[CBMX] CombiMatrix Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Hospital/Nursing Management

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 2.9 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart CBMX

Refresh chart

Strongest Trends Summary For CBMX

CBMX is in the long-term down -100% below S&P in 16 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: CombiMatrix Corporation provides molecular diagnostic solutions and clinical support services. It focuses on miscarriage analysis, prenatal testing, and pediatric genetics, as well as offers DNA-based testing for the detection of genetic abnormalities. The company develops and markets molecular testing services for prenatal/postnatal developmental disorders and hematology/oncology genomics. Its developmental disorder suite of array tests focus on the prenatal and postnatal application of microarrays in diagnosing genomic syndromes associated with intellectual disability, developmental delays, congenital anomalies, dysmorphic features, and autism spectrum disorders. The company?s oncology diagnostic tests include a series of diagnostic microarray tests that provide additional genomic information to physicians through the genetic analysis of blood, tissue, or biopsy samples. The microarray testing addresses various common hematological malignancies primarily chronic lymphocytic leukemia. The company serves comm

Fundamental Ratios
Shares Outstanding EPS-1.68 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 19.99% Sales Growth - Q/Q5.05% P/E-2.92
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-67.68% ROE-82.36% ROI
Current Ratio6.32 Quick Ratio6.13 Long Term Debt/Equity0.02 Debt Ratio0.18
Gross Margin45.44% Operating Margin-99.63% Net Profit Margin-99.15% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.71 M Cash From Investing Activities2.19 M Cash From Operating Activities-1.18 M Gross Profit1.1 M
Net Profit-1.76 M Operating Profit-1.75 M Total Assets12.52 M Total Current Assets11.56 M
Total Current Liabilities1.83 M Total Debt400 K Total Liabilities2.23 M Total Revenue2.33 M
Technical Data
High 52 week8.15 Low 52 week2.2 Last close6.25 Last change0%
RSI30.43 Average true range1.21 Beta0.73 Volume18.18 K
Simple moving average 20 days-10.82% Simple moving average 50 days-15.53% Simple moving average 200 days4.59%
Performance Data
Performance Week-3.25% Performance Month-21.38% Performance Quart-15.54% Performance Half14.68%
Performance Year131.48% Performance Year-to-date135.85% Volatility daily3.52% Volatility weekly7.87%
Volatility monthly16.12% Volatility yearly55.85% Relative Volume85.57% Average Volume43.29 K
New High New Low

News

2017-11-10 16:15:49 | CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

2017-11-10 09:00:00 | CBMX: Results Remain Very Strong, Despite Record Revenue Streak Ending

2017-11-06 16:01:00 | Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017

2017-11-06 06:00:00 | CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results

2017-11-02 16:55:10 | CombiMatrix Corporation Reminds Shareholders to Vote _FOR_ the Merger With Invitae Corporation

2017-11-01 16:05:00 | Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote _FOR_ the Proposed Merger with Invitae Corporation

2017-10-20 06:00:00 | CombiMatrix to Present New Data from a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting

2017-10-12 12:12:00 | SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of CombiMatrix Corporation - CBMX

2017-10-06 07:30:00 | Invitae Commences Exchange Offer for CombiMatrix Series F Warrants

2017-09-25 06:00:00 | CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae

2017-08-31 12:54:24 | CombiMatrix Corp. :CBMX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 31, 2017

2017-08-03 06:00:00 | CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results

2017-08-02 08:00:00 | Today's Research Reports on Trending Tickers: CombiMatrix Corporation and Puma Biotechnology

2017-08-01 17:39:00 | CombiMatrix shares jump on buyout news

2017-07-31 16:59:06 | CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock

2017-07-31 16:57:00 | Invitae Acquiring Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life

2017-05-29 09:11:50 | CombiMatrix Corp. :CBMX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 29, 2017

2017-05-22 06:00:00 | CombiMatrix to Present at Upcoming Investor Conferences

2017-05-08 08:00:00 | Today's Research Reports on Stocks to Watch: CombiMatrix and Eyegate Pharmaceuticals

2017-05-05 13:25:59 | Edited Transcript of CBMX earnings conference call or presentation 4-May-17 8:30pm GMT

2017-05-04 16:05:00 | CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results

2017-05-02 17:44:00 | SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating CombiMatrix Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors

2017-04-27 06:00:00 | CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017

2017-03-30 09:30:00 | CombiMatrix and Vertex Pharmaceuticals Make Gains

2017-03-17 11:33:29 | CombiMatrix Corp. :CBMX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017

2017-03-13 14:51:26 | CombiMatrix Corp. :CBMX-US: Earnings Analysis: 2016 By the Numbers : March 13, 2017

2017-03-03 16:39:29 | COMBIMATRIX CORP Files SEC form 10-K, Annual Report

2017-03-01 06:22:33 | COMBIMATRIX CORP Files SEC form 8-K, Change in Directors or Principal Officers

2017-03-01 06:00:00 | CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors

2017-03-01 06:00:00 | CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors

2017-02-28 11:00:00 | CBMX: Q4 Records On Almost Every Measure

2017-02-22 16:07:12 | COMBIMATRIX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits

2017-02-22 16:05:00 | CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results

2017-02-15 06:00:00 | CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017

2017-02-10 09:00:00 | CBMX:Expect Record Revenue, Profit in 2017 On Strong Fundamentals

2017-02-08 06:00:00 | CombiMatrix to Present at 2nd Annual Disruptive Growth & Healthcare Conference

2017-02-03 17:20:47 | COMBIMATRIX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits

2017-02-02 06:00:00 | CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board

2017-01-20 06:00:00 | CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss

2016-12-23 17:01:48 | COMBIMATRIX CORP Files SEC form 8-K, Change in Directors or Principal Officers

2016-11-29 06:03:00 | 6:03 am CombiMatrix announces that its pre-implantation genetic screening by next generation sequencing test has received conditional approval from the New York State Department of Health

2016-11-29 06:00:00 | CombiMatrix’s Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health

2016-11-07 17:24:24 | COMBIMATRIX CORP Files SEC form 10-Q, Quarterly Report

2016-11-07 10:00:00 | CBMX: Q3 Sets Across-The-Board Records. CF Break-Even Looks Attainable

2016-11-03 11:16:43 | CombiMatrix Corp. :CBMX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016

2016-11-02 13:53:19 | COMBIMATRIX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits

2016-11-02 07:07:04 | Q3 2016 CombiMatrix Corp Earnings Release - After Market Close

2016-11-02 06:10:13 | CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results

2016-11-02 06:00:00 | CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results

2016-10-26 06:05:07 | CombiMatrix Corporation to Release 2016 Third Quarter Financial Results on November 2, 2016